ANL Adlai Nortye Ltd.

NYSE
$15.76

Adlai Nortye Ltd. (ANL) is expected to report earnings on August 14, 2026, before the market open. The consensus earnings estimate is $0.03 per share.

Earnings Date
3rd Quarter, Sep 2026
Aug 14
Friday · 8:00 AM ET
Earnings Whisper
-
vs $0.03
Volatility
Enter your expectations below to reveal the current volatility.
Trend Analysis
Expectation
Earnings
Price action
Signals
Score
Sentiment
Grade
Life Cycle
Call Analysis
Earnings-AVWAP -

Sign in or subscribe to unlock sentiment, short interest, and technical indicators.

About Adlai Nortye Ltd.

Adlai Nortye Ltd. is a clinical-stage biotechnology company. It focused on the discovery and development of innovative cancer therapies for patients across the spectrum of tumor types. Adlai Nortye Ltd. is based in SINGAPORE.

Sector

Healthcare

Industry

Biotechnology

Charts powered in part by Lightweight Charts™ by TradingView.